Nath Bio-Genes (India) Limited (NATHBIOGEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.09 Billion ≈ $-11.75 Million USD) by net assets (Rs6.80 Billion ≈ $73.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Nath Bio-Genes (India) Limited for the company's overall valuation and market capitalisation.
Nath Bio-Genes (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2026)
This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency. Explore Nath Bio-Genes (India) Limited (NATHBIOGEN) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DOREL INDS INC. B
F:DO4B
|
-0.047x |
|
K-One Technology Bhd
KLSE:0111
|
-0.022x |
|
Vulcan Infrastructure and Power Inc.
NASDAQ:VIP
|
0.076x |
|
Klondike Gold Corp
V:KG
|
-0.008x |
|
Wave Electronics Co. Ltd
KQ:095270
|
-0.010x |
|
Laurion Mineral Exploration Inc
V:LME
|
-0.278x |
|
Exxaro Tiles Limited
NSE:EXXARO
|
0.054x |
|
Sapmer
PA:ALMER
|
0.004x |
Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2026)
The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. View today's stock price for Nath Bio-Genes (India) Limited for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs6.80 Billion ≈ $73.59 Million |
Rs-220.35 Million ≈ $-2.38 Million |
-0.032x | -218.69% |
| 2025-03-31 | Rs6.44 Billion ≈ $69.69 Million |
Rs175.81 Million ≈ $1.90 Million |
0.027x | -72.93% |
| 2024-03-31 | Rs6.10 Billion ≈ $65.96 Million |
Rs614.80 Million ≈ $6.65 Million |
0.101x | +50.59% |
| 2023-03-31 | Rs5.73 Billion ≈ $61.99 Million |
Rs383.67 Million ≈ $4.15 Million |
0.067x | +112.82% |
| 2022-03-31 | Rs5.42 Billion ≈ $58.61 Million |
Rs170.46 Million ≈ $1.84 Million |
0.031x | +1633.30% |
| 2021-03-31 | Rs6.13 Billion ≈ $66.32 Million |
Rs11.13 Million ≈ $120.35K |
0.002x | -89.32% |
| 2020-03-31 | Rs5.58 Billion ≈ $60.30 Million |
Rs94.74 Million ≈ $1.02 Million |
0.017x | +139.22% |
| 2019-03-31 | Rs5.08 Billion ≈ $54.89 Million |
Rs-219.89 Million ≈ $-2.38 Million |
-0.043x | +56.74% |
| 2018-03-31 | Rs4.69 Billion ≈ $50.75 Million |
Rs-469.84 Million ≈ $-5.08 Million |
-0.100x | -512.04% |
| 2017-03-31 | Rs1.38 Billion ≈ $14.88 Million |
Rs33.43 Million ≈ $361.58K |
0.024x | +120.81% |
| 2016-03-31 | Rs1.21 Billion ≈ $13.12 Million |
Rs-141.68 Million ≈ $-1.53 Million |
-0.117x | -285.23% |
| 2015-03-31 | Rs1.07 Billion ≈ $11.59 Million |
Rs67.55 Million ≈ $730.58K |
0.063x | -65.69% |
| 2014-03-31 | Rs817.78 Million ≈ $8.84 Million |
Rs150.28 Million ≈ $1.63 Million |
0.184x | -25.68% |
| 2013-03-31 | Rs574.74 Million ≈ $6.22 Million |
Rs142.11 Million ≈ $1.54 Million |
0.247x | -- |
About Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jow… Read more